Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906773 · ClinicalTrials.gov registry record
Advance Care Planning GuideTailored for Primary Care Patients
A clinical trial of Chronic Disease and Advance Care Planning, sponsored by Ohio State University.
- Completed
- Registry status
- 419
- Enrollment target
- 1
- Study location
NCT03906773: Completed study of Chronic Disease and Advance Care Planning, sponsored by Ohio State University.
NCT03906773 is a study of Chronic Disease and Advance Care Planning that has completed, run by Ohio State University. The registered enrollment target is 419 participants, below the 89,935-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03906773, a study of Chronic Disease and Advance Care Planning, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 419 participants
- Enrollment target
- 1
- Study location
Study Summary
this project seeks to: validate results of ACP framework pilot study in a larger randomized controlled trial (rates and quality of ACP documentation) prior to using participatory design to develop an Electronic Health Record (EHR)-tethered patient portal delivered ACP communication guide, tailored for use in busy primary care settings, incorporating patients, caregivers, and primary care providers
Primary Outcome
Presence of Electronic Health Record problem list based ACP documentation or presence of Electronic Health Record scanned completed Advance Directive document
Conditions Studied
Interventions
- OTHER Patient Centered Medical Home Based Electronic Framework for Advance Care Planning
Study Locations (1)
Ohio
- Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2017-04-30 |
| Est. Completion | 2018-12-15 |
What the finished NCT03906773 record still lists
NCT03906773 is an observational study that tracks outcomes without assigning an intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap, below the 89,935-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Patient Centered Medical Home Based Electronic Framework for Advance Care Planning is the first listed.
NCT03906773 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03906773 about?
NCT03906773 is a clinical study titled "Advance Care Planning GuideTailored for Primary Care Patients". this project seeks to: validate results of ACP framework pilot study in a larger randomized controlled trial (rates and quality of ACP documentation) prior to using participatory design to develop an Electronic Health Record (EHR)-tethered patient portal delivered ACP communication guide, tailored f...
What is the current status of trial NCT03906773?
This trial is currently completed. The enrollment target is 419 participants. The study started on 2017-04-30. Estimated completion is 2018-12-15.
What conditions does trial NCT03906773 study?
This clinical trial studies the following conditions: Chronic Disease, Advance Care Planning, Communication Research.
What interventions are being tested in trial NCT03906773?
The interventions under investigation include: Patient Centered Medical Home Based Electronic Framework for Advance Care Planning (OTHER).
Who is sponsoring clinical trial NCT03906773?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03906773 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03906773's enrollment target sits among peer trials
419 19th of 48 higher than 30 of 48 other Chronic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Click & Pick Study
RECRUITING · NA
-
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
RECRUITING · NA
-
RIVER At Home Ketamine Protocols
RECRUITING
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI